MRSA has creeping resistance to key drugs
Link: HighWire Press -- Medline Abstract.
Methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 3,189) from 2,990 patients were investigated by agar screening and by the E-test(TM) macromethod for reduced susceptibility to glycopeptide. No vancomycin-resistant S. aureus or glycopeptide-intermediate S. aureus (GISA) were detected but 178 isolates were confirmed as hetero-GISA (hGISA) by vancomycin population analysis profile (PAP)-area under the curve (vPAP-AUC) ratio determination and/or teicoplanin PAP (tPAP) methods. Of 139 isolates detected using the recommended E-test(TM) macromethod cut-off values of >/=8 mg/L for both vancomycin and teicoplanin or >/=12 mg/L for teicoplanin alone, 73 were confirmed as hGISA by vPAP-AUC, 95 by tPAP and 108 by both methods.